Reaction

Ventricular Dysfunction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,564 reports · 76 co-occurring drugs

As of the last recalculation, Ventricular Dysfunction appears in 2,564 FAERS reports alongside 76 co-occurring drug terms. The strongest observed disproportionality signal is ISOSORBIDE MONONITRATE (PRR 24.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Isosorbide Mononitrate	60	24.0	24.1
Pertuzumab	68	20.8	20.9
Trastuzumab	162	20.4	20.4
Fam-Trastuzumab Deruxtecan-Nxki	24	19.5	19.5
Doxorubicin	186	18.2	18.2
Doxorubicin Hydrochloride	71	18.1	18.2
Ampicillin	17	16.8	16.8
Ampicillin Sodium	17	16.8	16.8
Methimazole	13	13.5	13.5
Quetiapine Fumarate	45	12.6	12.6
Nitroglycerin	79	12.3	12.3
Captopril	14	11.9	11.9
Eplerenone	18	11.5	11.5
Digoxin	94	11.0	11.0
Vincristine Sulfate	39	11.0	11.0
Amiodarone Hydrochloride	15	10.9	10.9
Propofol	47	10.6	10.6
Acetylcysteine	12	10.4	10.4
Enalapril Maleate	31	10.3	10.3
Metolazone	14	10.2	10.2
Sevoflurane	10	9.8	9.8
Polyethylene Glycol	11	8.3	8.3
Venlafaxine	70	8.1	8.1
Isosorbide Dinitrate	19	8.0	8.0
Ramipril	116	7.9	7.9
Mesna Injection	8	7.9	7.9
Mesna	8	7.7	7.7
Ado-Trastuzumab Emtansine	8	7.7	7.7
Norepinephrine Bitartrate	13	7.4	7.4
Phenobarbital	13	7.3	7.3
Tolterodine Tartrate	8	7.3	7.3
Cefazolin	8	7.1	7.1
Bumetanide	23	7.1	7.1
Glyburide	21	7.1	7.1
Amlodipine Besylate And Benazepril Hydrochloride	8	7.1	7.1
Phenytoin	18	7.0	7.1
Carvedilol	111	6.9	6.9
Norepinephrine	9	6.9	6.9
Carfilzomib	23	6.7	6.7
Anakinra	13	6.4	6.4
Midazolam Hydrochloride	21	6.4	6.4
Oxaliplatin	57	6.4	6.4
Fluorouracil	59	6.3	6.3
Fluorouracil Cream, 0.5%	58	6.3	6.3
Gentamicin	10	6.2	6.2
Midazolam	19	6.2	6.2
Ganciclovir Sodium	8	6.2	6.2
Ivacaftor	6	6.1	6.1
Melphalan	17	6.1	6.1
Cefazolin Sodium	9	6.1	6.1
Furosemide	269	6.0	6.0
Cyclophosphamide Injection, Solution	123	5.9	5.9
Cyclophosphamide	123	5.9	5.9
Cyclophosphamide For Injection	123	5.9	5.9
Human Insulin	9	5.9	5.9
Enalapril	39	5.8	5.8
Ifosfamide	15	5.7	5.7
Melphalan Hydrochloride	17	5.5	5.5
Sirolimus	9	5.4	5.4
Conjugated Estrogens	34	4.8	4.8
Fosaprepitant Dimeglumine	8	4.7	4.7
Trametinib	14	4.7	4.7
Sacubitril And Valsartan	66	4.7	4.7
Estrogens, Conjugated	34	4.7	4.7
Dofetilide	6	4.6	4.6
Romiplostim	8	4.3	4.3
Etoposide	38	4.2	4.2
Loratadine And Pseudoephedrine Sulfate	4	4.1	4.1
Osimertinib	14	3.6	3.6
Cisplatin	33	3.5	3.5
Tafamidis	5	3.5	3.5
Carboplatin	53	3.4	3.4
Clozapine	52	3.4	3.4
Pemetrexed Disodium	14	3.0	3.0
Dornase Alfa	6	2.5	2.5
Aflibercept	8	2.1	2.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.